Asston Pharmaceu

{
  "main_header": {
    "sid": 10039662,
    "name": "Asston Pharmaceu",
    "stock_name": "Asston Pharmaceu",
    "full_name": "Asston Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/asston-pharmaceu",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "73.01",
    "chg": 3.01,
    "chgp": "4.3%",
    "dir": 1,
    "prev_price": "70.00",
    "mcapval": "60.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 544445,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE0SJX01015",
    "curr_date": "May 27",
    "curr_time": "",
    "bse_nse_vol": 2000,
    "exc_status": "Active",
    "traded_date": "May 27, 2026",
    "traded_date_str": "2026 05 27",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/asston-pharmaceu-10039662-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Asston Pharmaceuticals Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-asston-pharmaceuticals-ltd-4007526",
        "imagepath": "",
        "date": "2026-05-22 23:21:40",
        "description": "The next results date for Asston Pharmaceuticals Ltd is scheduled for 29 May 2026...."
      }
    ],
    "total": 7,
    "sid": "10039662",
    "stock_news_url": "https://www.marketsmojo.com/news/asston-pharmaceuticals-10039662"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Approving Audited Financial Ressults",
      "datetime": "21-May-2026",
      "details": "Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve 1. To consider and approve the Audited Financial Statements and Financial Results along with the Audit report for the Financial Year and Quarter ended 31st March 2026; 2. To consider and approve the statement of deviation of funds pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015; 3. Other Incidental Matter.",
      "source": "BSE"
    },
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "30-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Asston Pharmaceuticals Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>U24304MH2019PLC324187</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>5.04</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: RISHI UPADHAYA <br/> Designation: COMPANY SECRETARY <br/> EmailId: COMPLIANCE@ASSTONPHARMACEUTICALS.COM</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: SUMIT PAWAR <br/> Designation: CFO <br/> EmailId: SUMITPAWAR98675@GMAIL.COM</div> </div> <div> <br/> Date: 30/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of EGM",
      "datetime": "28-Apr-2026",
      "details": "Outcome and Proceedings of the Extraordinary General Meeting held on 28th April 2026 through (VC-OAVM).",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "29 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

When is the next results date for Asston Pharmaceuticals Ltd?

2026-05-22 23:21:40

The next results date for Asston Pharmaceuticals Ltd is scheduled for 29 May 2026....

Read full news article

View All News